NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $1.58 +0.03 (+1.60%) Closing price 03:59 PM EasternExtended Trading$1.59 +0.01 (+0.38%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Envoy Medical Stock (NASDAQ:COCH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Envoy Medical alerts:Sign Up Key Stats Today's Range$1.55▼$1.7050-Day Range$1.26▼$1.7252-Week Range$1.21▼$3.99Volume80,831 shsAverage Volume81,034 shsMarket Capitalization$33.80 millionP/E RatioN/ADividend YieldN/APrice Target$9.25Consensus RatingBuy Company OverviewEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Read More… Envoy Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreCOCH MarketRank™: Envoy Medical scored higher than 66% of companies evaluated by MarketBeat, and ranked 416th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Envoy Medical are expected to decrease in the coming year, from ($1.21) to ($1.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envoy Medical is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Envoy Medical is -1.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Envoy Medical's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.70% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envoy Medical has recently decreased by 16.63%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.70% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envoy Medical has recently decreased by 16.63%, indicating that investor sentiment is improving significantly. News and Social Media3.0 / 5News Sentiment1.44 News SentimentEnvoy Medical has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Envoy Medical this week, compared to 0 articles on an average week.MarketBeat FollowsOnly 1 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $82,430.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders60.50% of the stock of Envoy Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address COCH Stock News HeadlinesCharles Brynelsen Acquires 13,000 Shares of Envoy Medical, Inc. (NASDAQ:COCH) StockMay 28 at 5:46 AM | insidertrades.comEnvoy Medical (COCH) Expected to Announce Quarterly Earnings on WednesdayMay 19, 2025 | americanbankingnews.comElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.May 28, 2025 | GoldenCrest Metals (Ad)Envoy Medical advances in cochlear implant trialMay 14, 2025 | investing.comEnvoy Medical (COCH) Receives a Buy from Northland SecuritiesApril 24, 2025 | markets.businessinsider.comEdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap CompaniesApril 22, 2025 | globenewswire.comEnvoy Medical secures new patents for cochlear implantsFebruary 15, 2025 | msn.comEnvoy Medical announces four new patentsDecember 17, 2024 | markets.businessinsider.comSee More Headlines COCH Stock Analysis - Frequently Asked Questions How have COCH shares performed this year? Envoy Medical's stock was trading at $1.43 at the beginning of 2025. Since then, COCH shares have increased by 10.8% and is now trading at $1.5850. View the best growth stocks for 2025 here. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) announced its quarterly earnings data on Friday, March, 28th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.33) by $0.12. The company earned $0.04 million during the quarter, compared to the consensus estimate of $0.07 million. Who are Envoy Medical's major shareholders? Top institutional shareholders of Envoy Medical include Focus Partners Wealth (1.00%) and Arcus Capital Partners LLC (0.88%). Insiders that own company stock include Brent T Lucas, Charles Brynelsen and Mona Chetan Patel. View institutional ownership trends. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envoy Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPeng (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO) and CrowdStrike (CRWD). Company Calendar Last Earnings3/28/2025Today5/28/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:COCH CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Stock Price Target$9.25 High Stock Price Target$9.50 Low Stock Price Target$9.00 Potential Upside/Downside+464.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.91 million Net Margins-7,607.55% Pretax Margin-7,607.55% Return on EquityN/A Return on Assets-262.28% Debt Debt-to-Equity RatioN/A Current Ratio0.79 Quick Ratio0.61 Sales & Book Value Annual Sales$212,000.00 Price / Sales164.98 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-18.22Miscellaneous Outstanding Shares21,327,000Free Float7,997,000Market Cap$34.98 million OptionableNot Optionable Beta2.33 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:COCH) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.